Edition:
India

Array Biopharma Inc (ARRY.OQ)

ARRY.OQ on NASDAQ Stock Exchange Global Market

10.82USD
12:26am IST
Change (% chg)

$-0.30 (-2.70%)
Prev Close
$11.12
Open
$11.15
Day's High
$11.19
Day's Low
$10.75
Volume
677,942
Avg. Vol
942,461
52-wk High
$13.38
52-wk Low
$6.74

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep 29.75 -0.217
FY 2017 Jun '17 33.78 -0.173
Mar '17 33.28 -0.209
Dec 44.52 -0.139
Sep 39.27 -0.197
FY 2016 Jun '16 43.21 -0.174
Mar '16 43.05 -0.158
Dec 35.43 -0.169
Sep 16.20 -0.148
FY 2015 Jun '15 12.32 -0.090
Mar '15 6.60 0.351
Dec 26.92 -0.064
Sep 6.07 -0.209
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-17 9 28.60 37.00 13.00 --
Quarter Ending Sep-18 2 30.36 45.00 15.73 --
Year Ending Jun-17 9 144.51 150.40 130.10 --
Year Ending Jun-18 9 109.83 170.00 63.00 143.31
Year Ending Jun-19 9 186.77 349.89 78.20 252.15
Earnings (per share)
Quarter Ending Jun-17 9 -0.21 -0.01 -0.29 --
Quarter Ending Sep-18 1 0.11 0.11 0.11 --
Year Ending Jun-17 9 -0.76 -0.56 -0.86 --
Year Ending Jun-18 9 -0.99 -0.71 -1.27 -0.77
Year Ending Jun-19 9 -0.58 0.44 -1.52 -0.07
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 9.41 53.05 12.12
EPS (TTM) % -10.22 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Array Biopharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 263
Total Shares Held: 201,730,327
3 Mo. Net Change: 26,084,330
# New Positions: 46
# Closed Positions: 39
# Increased Positions: 130
# Reduced Positions: 103
# Net Buyers: 27
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.